PMS-DEFERASIROX

Pharmascience Inc🇨🇦 Health Canada

Approval Id: fdfb47729aeb3638
Drug Approval Canada Name: PMS-DEFERASIROX
Product Name: PMS-DEFERASIROX
Status: Marketed
Status Date: 2018-04-25
Original Market Date: 2018-04-25
Din: 02474336
Drug Class: Human
Dosage Form: Tablet For Suspension
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 64:00.00
Atc Original: V03AC03 DEFERASIROX
Atc Name: v 03 ac 03
Aig Number: 0151733002
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

DEFERASIROX

250 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

fdfb47729aeb3638

Type

Standard